Heather A. Jacene

2 ta ish

Dana-Farber Cancer Institute

1. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors

   Richard L. Wahl, Heather A. Jacene, Yvette L. Kasamon +1

   Sharh maqola20095 iqtibos

   ABIABI:AkademIndex/2026.other.413769

2. Phase 3 Trial of ¹⁷⁷ Lu-Dotatate for Midgut Neuroendocrine Tumors

   Jonathan Strosberg, Ghassan El‐Haddad, Edward M. Wolin +32

   MaqolaOAOchiq kirish20173 iqtibos

   ABIABI:AkademIndex/2026.other.011754